OnClarity
onclarity.com
Actively hiring
AI Agents
Software Testing & QA
Customer Support & Help Desk Software
As featured in
Follow
Overview
News
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Backers
2
STV, Wamda Capital
Momentum
0/100
no fresh signals
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2022
Founded
Backed byfrom the funds' portfolios and accelerator catalogs
STV 
Wamda Capital Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
The governed agentic AI platform for customer experience. Aide resolves issues end-to-end inside your helpdesk and surfaces what to…
TestMu is an AI-powered software testing platform, automating test creation, execution, and analysis via autonomous AI agents to support…
Ship faster, break less. Spur is the agentic QA platform that tests your e-commerce site end-to-end, catching bugs before your customers…
Krista builds your Enterprise Brain. The agentic platform unifies people, systems, and AI so your business remembers, reasons, and acts as…
Sortd turns Gmail into a shared inbox and visual workflow: every conversation in support@, sales@ and orders@ gets an owner, a status and a…
Pylon is a customer support software company headquartered in San Francisco, California, and founded in 2022. The company builds a support…
News
FDA clears Onclarity HPV Self-Collection Kit for at-home cervical cancer screening
The FDA has cleared an HPV self-collection kit and approved a related HPV assay for at-home use, enabling patients to obtain their own sample for cervical cancer screening.The Onclarity HPV Self-Collection Kit (Waters Corp.) is tested with the BD Onclarit
Read more
Report
BD Onclarity HPV Assay for BD COR and BD Viper LT Systems Receive WHO Prequalification
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the Conformité Européenne (CE) Marked BD Onclarity HPV Assay for the BD COR System and the BD Viper LT System have been accepted for the Worl
Read more
Report
BD Onclarity HPV Assay for BD COR and BD Viper LT Systems Receive WHO Prequalification
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the Conformité Européenne (CE) Marked BD Onclarity HPV Assay for the BD COR System and the BD Viper LT System have been accepted for the Worl
Read more
Report
BD Onclarity HPV Assay for BD COR and BD Viper LT Systems Receive WHO Prequalification
/PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the Conformité Européenne...
Read more
Report
BD Onclarity HPV Assay Receives FDA Approval for Use with Both BD SurePath Liquid-based Pap Test and Hologic ThinPrep Pap Test
--BD, a leading global medical technology company, today announced U.S. Food and Drug Administration market approval for the BD Onclarity HPV Assay to be used with the ThinPrep Pap Test. The BD SurePath Liquid-based Pap Test vial and the Hologic ThinPrep
Read more
Report
BD Submits Pre-Market Approval Supplement to FDA to Enable ThinPrep Pap Test PreservCyt Solution to be Used with the BD Onclarity HPV Assay
--BD, a leading global medical technology company, today announced that it has submitted a pre-market approval supplement to the U.S. Food and Drug Administration for the use of the ThinPrep Pap Test PreservCyt Solution vial as an approved sample type for
Read more
Report